Capital Asset Advisory Services LLC Spero Therapeutics, Inc. Transaction History
Capital Asset Advisory Services LLC
- $2.13 Billion
- Q2 2025
A detailed history of Capital Asset Advisory Services LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 32,548 shares of SPRO stock, worth $95,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,548Holding current value
$95,691% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SPRO
# of Institutions
43Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX3.8MShares$11.2 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$5.19 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.98 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.85 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.62 Million0.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $103M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...